<SEC-DOCUMENT>0000920465-15-000080-index.html : 20151112 <SEC-HEADER>0000920465-15-000080.hdr.sgml : 20151112 <ACCEPTANCE-DATETIME>20151112164536 ACCESSION NUMBER: 0000920465-15-000080 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20151106 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151112 DATE AS OF CHANGE: 20151112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 151225461 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a8-k2015q3earningsrelease.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a8-k2015q3earningsrelease.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>a9912015q3earningspressrel.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: a9912015q3earningspressrel.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ljpcpressrelease_image1.jpg <TEXT> Document 3 - file: ljpcpressrelease_image1.jpg
</DOCUMENT> </SEC-DOCUMENT>